Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA ’ s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health

Commissioner statement on FDA ’ s comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy
Source: Food and Drug Administration - Category: American Health Source Type: news